« previous next »
Pages: [1]

Author Topic: (Abst.) Severe disease activity in a patient w/MS after daclizumab discontinuation  (Read 98 times)

0 Members and 0 Guests are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 9480
  • MS diagnosed 1980
  • Location: Pacific Northwest
(Abst.) Severe disease activity in a patient w/MS after daclizumab discontinuation
« on: December 17, 2018, 10:02:37 am »

From PubMed, December 17, 2018--"Severe disease activity in a patient with multiple sclerosis after daclizumab discontinuation":


https://www.ncbi.nlm.nih.gov/pubmed/30554038

Daclizumab (Zinbryta) has been taken off the market. For some background, here is a thread from a few months ago about it:


https://msspeaks.createaforum.com/treatments/zinbryta-being-pulled-from-market-due-to-safety-concerns/msg2172/#msg2172

Report to moderator   Logged
MS Speaks--online for 16 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) since 12/16/20.
Pages: [1]
« previous next »
 

Related Topics

  Subject / Started by Replies Last post
0 Replies
141 Views 		Last post April 07, 2016, 02:12:24 pm
by agate
2 Replies
194 Views 		Last post December 26, 2018, 11:46:15 am
by agate
0 Replies
110 Views 		Last post August 03, 2018, 09:29:58 pm
by agate
0 Replies
57 Views 		Last post December 22, 2019, 08:50:14 pm
by agate
0 Replies
45 Views 		Last post May 15, 2020, 12:36:31 pm
by agate